List of Tables
Table 1. Major Company of Shanchol
Table 2. Major Company of Dukoral
Table 3. Major Company of Vaxchora
Table 4. Major Company of Others
Table 5. Global Cholera Vaccine (Oral Route) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 7. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US& Million)
Table 9. Global Cholera Vaccine (Oral Route) Market Share in Value by Type (2018-2023)
Table 10. Global Cholera Vaccine (Oral Route) Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (K Units)
Table 12. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Cholera Vaccine (Oral Route) Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Type (2024-2029)
Table 15. Global Cholera Vaccine (Oral Route) Price by Type (2024-2029) & (USD/Unit)
Table 16. North America Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 17. North America Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
Table 19. Europe Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
Table 21. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
Table 23. Latin America Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales (K Units) by Type (2018-2023)
Table 25. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Cholera Vaccine (Oral Route) Sales by Company (2018-2023) & (K Units)
Table 27. Global Cholera Vaccine (Oral Route) Sales Share by Company (2018-2023)
Table 28. Global Cholera Vaccine (Oral Route) Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Cholera Vaccine (Oral Route) Revenue Share by Company (2018-2023)
Table 30. Global Market Cholera Vaccine (Oral Route) Price by Company (2018-2023) & (USD/Unit)
Table 31. Global Cholera Vaccine (Oral Route) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Cholera Vaccine (Oral Route) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cholera Vaccine (Oral Route) as of 2022)
Table 34. Date of Key Manufacturers Enter into Cholera Vaccine (Oral Route) Market
Table 35. Key Manufacturers Cholera Vaccine (Oral Route) Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Cholera Vaccine (Oral Route) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (K Units)
Table 39. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2018-2023)
Table 42. Global Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 43. Global Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (K Units)
Table 44. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2024-2029)
Table 47. Global Cholera Vaccine (Oral Route) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 48. Global Cholera Vaccine (Oral Route) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 50. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2018-2023)
Table 53. Global Cholera Vaccine (Oral Route) Price by Application (2018-2023) & (USD/Unit)
Table 54. Global Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (K Units)
Table 55. Global Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Cholera Vaccine (Oral Route) Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Cholera Vaccine (Oral Route) Sales Market Share in Value by Application (2024-2029)
Table 58. Global Cholera Vaccine (Oral Route) Price by Application (2024-2029) & (USD/Unit)
Table 59. North America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
Table 60. North America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
Table 62. Europe Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
Table 64. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
Table 66. Latin America Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2018-2023) (K Units)
Table 68. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 70. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
Table 73. North America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
Table 74. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 78. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
Table 82. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Cholera Vaccine (Oral Route) Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 94. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 102. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Cholera Vaccine (Oral Route) Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Country (2024-2029)
Table 109. PaxVax Company Information
Table 110. PaxVax Introduction and Business Overview
Table 111. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. PaxVax Cholera Vaccine (Oral Route) Product
Table 113. PaxVax Recent Development
Table 114. Sanofi Company Information
Table 115. Sanofi Introduction and Business Overview
Table 116. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Sanofi Cholera Vaccine (Oral Route) Product
Table 118. Sanofi Recent Development
Table 119. Valneva Company Information
Table 120. Valneva Introduction and Business Overview
Table 121. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Valneva Cholera Vaccine (Oral Route) Product
Table 123. Valneva Recent Development
Table 124. EuBiologics Company Information
Table 125. EuBiologics Introduction and Business Overview
Table 126. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. EuBiologics Cholera Vaccine (Oral Route) Product
Table 128. EuBiologics Recent Development
Table 129. Key Raw Materials Lists
Table 130. Raw Materials Key Suppliers Lists
Table 131. Cholera Vaccine (Oral Route) Market Trends
Table 132. Cholera Vaccine (Oral Route) Market Drivers
Table 133. Cholera Vaccine (Oral Route) Market Challenges
Table 134. Cholera Vaccine (Oral Route) Market Restraints
Table 135. Cholera Vaccine (Oral Route) Distributors List
Table 136. Cholera Vaccine (Oral Route) Downstream Customers
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Cholera Vaccine (Oral Route) Product Picture
Figure 2. Global Cholera Vaccine (Oral Route) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Cholera Vaccine (Oral Route) Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Cholera Vaccine (Oral Route) Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Shanchol
Figure 6. Global Shanchol Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Dukoral
Figure 8. Global Dukoral Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Vaxchora
Figure 10. Global Vaxchora Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Cholera Vaccine (Oral Route) Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Cholera Vaccine (Oral Route) Sales Market Share by Type in 2022 & 2029
Figure 15. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 16. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 17. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 18. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 21. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Cholera Vaccine (Oral Route) Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Cholera Vaccine (Oral Route) Revenue in 2022
Figure 27. Cholera Vaccine (Oral Route) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Hospital
Figure 29. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Research & Academic Laboratories
Figure 31. Global Research & Academic Laboratories Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Pharmaceutical & Biotechnology Companies
Figure 33. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Cholera Vaccine (Oral Route) Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Cholera Vaccine (Oral Route) Sales Market Share by Application in 2022 & 2029
Figure 38. North America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 39. North America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 40. Europe Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 41. Europe Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 44. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Cholera Vaccine (Oral Route) Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Cholera Vaccine (Oral Route) Manufacturing Cost Structure
Figure 49. Cholera Vaccine (Oral Route) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed